Cold atmospheric plasma: Novel opportunities for tumor microenvironment targeting
Authors:
Open Access
- 10 February 2023
- journal article
- review article
- Published by Wiley in Cancer Medicine
- Vol. 12 (6) , 7189-7206
Abstract
With mounting preclinical and clinical evidences on the prominent roles of the tumor microenvironment (TME) played during carcinogenesis, the TME has been recognized and used as an important onco‐therapeutic target during the past decade. Delineating our current knowledge on TME components and their functionalities can help us recognize novel onco‐therapeutic opportunities and establish treatment modalities towards desirable anti‐cancer outcome. By identifying and focusing on primary cellular components in the TME, that is, tumor‐infiltrating lymphocytes, tumor‐associated macrophages, cancer‐associated fibroblasts and mesenchymal stem cells, we decomposed their primary functionalities during carcinogenesis, categorized current therapeutic approaches utilizing traits of these components, and forecasted possible benefits that cold atmospheric plasma, a redox modulating tool with selectivity against cancer cells, may convey by targeting the TME. Our insights may open a novel therapeutic avenue for cancer control taking advantages of redox homeostasis and immunostasis.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (JUSRP22011)
- National Natural Science Foundation of China (81972789)
This publication has 226 references indexed in Scilit:
- Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarizationBMC Cancer, 2013
- Fibroblasts Contribute to Melanoma Tumor Growth and Drug ResistanceMolecular Pharmaceutics, 2011
- Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP productionJournal of Clinical Investigation, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Adipose Tissue–derived Mesenchymal Stem Cells Expressing Prodrug-converting Enzyme Inhibit Human Prostate Tumor GrowthMolecular Therapy, 2010
- Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicityProceedings of the National Academy of Sciences, 2009
- Cancer gene therapy using mesenchymal stem cells expressing interferon-β in a mouse prostate cancer lung metastasis modelGene Therapy, 2008
- Carcinoma-Associated Fibroblast–Like Differentiation of Human Mesenchymal Stem CellsCancer Research, 2008
- Activated macrophages promote Wnt signalling through tumour necrosis factor‐α in gastric tumour cellsThe EMBO Journal, 2008
- Tumor macrophage redox and effector mechanisms associated with hypoxiaFree Radical Biology and Medicine, 2006